[The media] needs to inform the public without terrorizing the public. We're prepared to defend our products in the public domain. |
Fortunately, this happened in a strong economy, ... But I don't think anyone would say it will be positive. |
On all measures of financial performance, Pfizer/Warner-Lambert significantly outperforms Warner-Lambert with American Home Products. |
This is an important victory not only for Pfizer but for all innovators pursuing high-risk medical discoveries. |
We are evaluating our financial prospects for 2006 and 2007 in light of current and anticipated business conditions, and are withdrawing our prior guidance for those years, |
We are moving from what I call the 'old Pfizer,' a company characterized by the medicines we launched so successfully in the 1990s, to the 'next generation' Pfizer, characterized by a new wave of important medicines now reaching patients. |
We share some of your disappointment in some of the news reported today, ... Beyond the quarterly numbers, we ask you to look at the greater picture of a Pfizer in transition. |